Cellular Biomedicine Group, Inc. , a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies, will visit the NASDAQ MarketSite in Times Square.
http://ift.tt/1p66YBb
http://ift.tt/1p66YBb
No comments:
Post a Comment